Metformin in Pregnant PCOS Women

PHASE3CompletedINTERVENTIONAL
Enrollment

257

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Metformin

Metformin 1000 mg x 2 per day. Orally. From inclusion (before gestational week 12) to delivery. Verbal and written diet and lifestyle advices at inclusion to the study

DRUG

Placebo

Placebo, 2 tablets x 2 daily.Orally. From inclusion (that is before gestational week 12) to delivery. Verbal and written diet and lifestyle advices at inclusion to the study

Trial Locations (10)

Unknown

Ålesund Hospital, Ålesund

University hospital of Bergen, Bergen

Central Hospital of Northern Norway, Bodø

Buskerud Hospital, Drammen

Haugesund Hospital, Haugesund

Ringerike Hospital, Hønefoss

Elvebredden Gynekologpraksis, Kristiansand

Lillehammer Hospital, Lillehammer

Stavanger University Hospital, Stavanger

Departments of Obstetrics and Gynecology and Endocrinology, St. Olav's Hospital, Trondheim

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

lead

Norwegian University of Science and Technology

OTHER

NCT00159536 - Metformin in Pregnant PCOS Women | Biotech Hunter | Biotech Hunter